GSK Stockmann supported the Swedish Catella Group with the strategic merger of two of its German subsidiaries, Catella Residential Investment Management (CRIM) in Berlin and Catella Real Estate AG (CREAG) in Munich. As of 1 January 2025, the new company Catella Investment Management (CIM) will combine both subsidiaries’ expertise into a single investment platform, further enhancing the group��s efficiency.

The aim of the merger to form Catella Investment Management is to create a stronger platform for the management of fund investments and provide an even better service for investors and partners. The platform will offer clients access to a multi-sector investment and asset manager with assets under management totalling approximately ten billion euros spread across more than 25 different funds and with properties in 15 different countries.

CIM provides advice on portfolio management, acquisitions, disposals and asset management and will have offices in Berlin, Munich and Vienna. The Catella Group is a leading specialist in property investments and fund management, with operations in 15 countries.

A GSK Stockmann team led by Munich partner Oliver Glück provided Catella with comprehensive advice on regulatory and corporate law issues in connection with the restructuring together with EY.

Advisers of Catella at GSK Stockmann:

Oliver Glück (lead, financial services), Andreas Dimmling (restructuring), Sascha Zentis, Dominik Stolz (financial services), Christina Lorf (restructuring)